Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Asami Nuno"'
Autor:
Keisuke Ishizawa, Yuki Izawa-Ishizawa, Noriko Yamano, Maki Urushihara, Takumi Sakurada, Masaki Imanishi, Shoko Fujii, Asami Nuno, Licht Miyamoto, Yoshitaka Kihira, Yasumasa Ikeda, Shoji Kagami, Hiroyuki Kobori, Koichiro Tsuchiya, Toshiaki Tamaki
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e86335 (2014)
Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Re
Externí odkaz:
https://doaj.org/article/171e1c4f16914815bf4922eb6ed4bbf0
Autor:
Shoko Fujii, Keisuke Ishizawa, Takumi Sakurada, Noriko Yamano, Yuki Izawa-Ishizawa, Masaki Imanishi, Asami Nuno, Yuta Suzuki, Yoshitaka Kihira, Yasumasa Ikeda, Shuhei Tomita, Koichiro Tsuchiya, Toshiaki Tamaki
Publikováno v:
Hypertension. 60
Diabetic nephropathy (DN) is a major microvascular complication of diabetes involving oxidative stress and endothelial damage. Nitrosonifedipine (NO-NIF) is converted from nifedipine under the light illumination. The ability of NO-NIF to block calciu
Autor:
Yuki Izawa-Ishizawa, Shoko Fujii, Koichiro Tsuchiya, Shuhei Tomita, Keisuke Ishizawa, Yoshitaka Kihira, Yasumasa Ikeda, Masaki Imanishi, Asami Nuno, Takumi Sakurada, Toshiaki Tamaki
Publikováno v:
The FASEB Journal. 26
Autor:
Maki Urushihara, Keisuke Ishizawa, Masaki Imanishi, Takumi Sakurada, Yuki Izawa-Ishizawa, Koichiro Tsuchiya, Toshiaki Tamaki, Hiroyuki Kobori, Shoko Fujii, Yasumasa Ikeda, Licht Miyamoto, Asami Nuno, Shoji Kagami, Yoshitaka Kihira, Noriko Yamano
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 1, p e86335 (2014)
PLoS ONE, Vol 9, Iss 1, p e86335 (2014)
Diabetic nephropathy (DN) is the major cause of end-stage renal failure. Oxidative stress is implicated in the pathogenesis of DN. Nitrosonifedipine (NO-NIF) is a weak calcium channel blocker that is converted from nifedipine under light exposure. Re